Blood transfusion: Quality and safety issues in thalassemia, basic requirements and new trends blood transfusion

Hemoglobin

Volumn 33, Issue SUPPL. 1, 2009, Pages

  Porter, John ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Blood transfusion; Guidelines; Thalassaemia

Indexed keywords

ALLOANTIBODY; AUTOANTIBODY; HEMOGLOBIN; IRON; IRON CHELATING AGENT;

ALLERGIC REACTION; ALLOIMMUNIZATION; AUTOIMMUNE HEMOLYTIC ANEMIA; BACTERIAL INFECTION; BLOOD GROUP ABO SYSTEM; BLOOD GROUP RHESUS SYSTEM; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BLOOD VOLUME; CELL FUNCTION; CELL VIABILITY; CHELATION THERAPY; CONFERENCE PAPER; CREUTZFELDT JAKOB DISEASE; ERYTHROCYTE; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE PRESERVATION; ERYTHROPOIESIS; FEVER; GRAFT VERSUS HOST REACTION; HEMATOCRIT; HEMOLYSIS; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; IRON BALANCE; LEUKOPENIA; PARASITOSIS; RISK; SPLEEN; SPLENECTOMY; SYPHILIS; THALASSEMIA; THALASSEMIA MAJOR; TRANSFUSION RELATED ACUTE LUNG INJURY; TREATMENT RESPONSE; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

BLOOD TRANSFUSION; ERYTHROCYTE TRANSFUSION; GREAT BRITAIN; HEMATOCRIT; HUMANS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; RISK FACTORS; THALASSEMIA;

EID: 73949146037     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630260903346593     Document Type: Conference Paper

References (22)

1. TIF. Guidelines for Clinical Management of Thalassaemia. (Book). Revised 2nd ed. Capellini, N, Cohen, A, Eleftheriou, A, Piga, A, Porter, JB, Taher, A, eds. Thalassaemia International Federation, Nicosia, Cyprus; 2008.
2. Hogman CF. Preparation and preservation of red cells. Vox Sang. 1998;74(Suppl.2):177-187.
3. Sprogoe-Jakobsen U, Saetre AM, Georgsen J. Preparation of white cell-reduced red cells by filtration: Comparison of a beside filter and two blood bank filter systems. Transfusion. 1995;35:421-426.
4. Buchholz DH, AuBuchon JP, Snyder EL, et al. Removal of yersinia enterocolitica from AS-1 red cells. Transfusion. 1992;32:667-672.
5. Spanos T, Karageorga M, Ladis V, Peristeri J, Hatziliami A, Kattamis C. Red cell alloantibodies in patients with thalassemia. Vox Sang. 1990;58:50-55.
6. Rebulla P, Modell B. Transfusion requirements and effects in patients with thalassaemia major. Cooleycare Programme. Lancet. 1991;337:277-280.
7. Cunningham MJ, Macklin EA, Singer ST, et al. Red blood cell allo- and autoantibodies in the thalassemia clinical research network. Blood 2005;106: Abstract 1890.
8. TIF. In A. Elefteriou (ed.) Blood Safety Kit: Thalassaemia International Federation; 1999.
9. Pelletier JP, Transue S, Snyder EL. Pathogen inactivation techniques. Best Pract Res Clin Haematol. 2006;19:205-242.
10. Solheim BG. Pathogen reduction of blood components. Transfus Apher Sci. 2008;39:75-82.
11. Lu SJ, Feng Q, Park JS, et al. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood. 2008;112:4475-4484.
12. Cazzola M, De Stefano P, Ponchio L, et al. Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major. Br J Haematol. 1995;89:473-478.
13. Cazzola M, Borgna-Pignatti C, Locatelli F, Ponchio L, Beguin Y, De Stefano P. A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis. Transfusion. 1997;37:135-140.
14. Gabutti V, Piga A, Nicola P, et al. Haemoglobin levels and blood requirement in thalassaemia. Arch Dis Child. 1982;57:156-157.
15. Propper RD, Button LN, Nathan DG. New approaches to the transfusion management of thalassemia. Blood. 1980;55:55-60.
16. Brunengo MA, Girot R. Transfusion requirements and mean annual hemoglobin level in thalassemia major. Nouv Rev Fr Hematol. 1986;28:309-313.
17. Porter JB. Practical management of iron overload. Br J Haematol. 2001;115:239-252.
18. Cohen AR, Glimm E, Porter JB. Effect of transfusional iron intake on response to chelation therapy in beta-thalassemia major. Blood. 2008;111:583-587.
19. Graziano JH, Piomelli S, Hilgartner M, et al. Chelation therapy in beta-thalassemia major. III. The role of splenectomy in achieving iron balance. J Pediatr. 1981;99:695-699.
20. Cohen AR, Glimm E, Porter JB. Effect of transfusional iron intake on response to chelation therapy in beta-thalassemia major. Blood. 2008;111:583-587.
21. O'Brien RT, Pearson HA, Spencer RP. Transfusion-induced decrease in spleen size in thalassemia major: Documentation by radioisotopic scan. J Pediatr. 1972;81:105-107.
22. Modell B. Total management of thalassaemia major. Arch Dis Child. 1977;52:485-500.